In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia

被引:12
作者
Lim, SH [1 ]
Coleman, S [1 ]
Bailey-Wood, R [1 ]
机构
[1] Univ Wales Coll Med, Dept Haematol, Cardiff CF4 4XN, S Glam, Wales
关键词
CML; immunogenicity; costimulatory molecules;
D O I
10.1038/sj.bmt.1701511
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We previously showed that in chronic myeloid leukaemia (CML), it is possible to induce costimulatory molecules, CD80/CD86, on leukaemia cells by culturing adherent peripheral blood mononuclear cells from these patients with IL-4 and GM-CSF, In addition to the expression of CD80/CD86 molecules, some of the leukaemia cells also expressed the dendritic cell marker, CD1a, When these leukaemia cells were used in mixed lymphocyte leukaemia reactions, they mediated antologous T cell proliferation not seen when fresh leukaemia cells were used as the stimulator cells. In this study, we showed that reinfusion of these immunogenic leukaemia cells to the autologous hosts resulted in priming in vivo of T cells so that they could respond to subsequent rechallenge in vitro with fresh autologous leukaemia cells. Although cytotoxic T cells against leukaemia cells were not demonstrated, these T cells could proliferate and produce interferon-gamma when cocultured in vitro with the leukaemia cells, Our findings therefore provide further evidence for the immunogenicity of these cultured leukaemia cells in CML.
引用
收藏
页码:1185 / 1190
页数:6
相关论文
共 12 条
[1]   Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia [J].
Choudhury, A ;
Gajewski, JL ;
Liang, JC ;
Popat, U ;
Claxton, DF ;
Kliche, KO ;
Andreeff, M ;
Champlin, RE .
BLOOD, 1997, 89 (04) :1133-1142
[2]  
Coleman S, 1996, LEUKEMIA, V10, P483
[3]   Cytokine enhancement of immunogenicity in chronic myeloid leukaemia [J].
Coleman, S ;
Throp, D ;
Fisher, J ;
Bailey-Wood, R ;
Lim, SH .
LEUKEMIA, 1997, 11 (12) :2055-2059
[4]   ABNORMAL TCR V-BETA REPERTOIRE IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA [J].
COLEMAN, S ;
PERERA, P ;
FISHER, J ;
HOY, T ;
BURNETT, AK ;
LIM, SH .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (02) :358-363
[5]   EFFECTIVE TUMOR VACCINE GENERATED BY FUSION OF HEPATOMA-CELLS WITH ACTIVATED B-CELLS [J].
GUO, YJ ;
WU, MC ;
CHEN, H ;
WANG, XN ;
LIU, GL ;
LI, GL ;
MA, J ;
SY, MS .
SCIENCE, 1994, 263 (5146) :518-520
[6]   ROLE OF BONE-MARROW-DERIVED CELLS IN PRESENTING MHC CLASS I-RESTRICTED TUMOR-ANTIGENS [J].
HUANG, AYC ;
GOLUMBEK, P ;
AHMADZADEH, M ;
JAFFEE, E ;
PARDOLL, D ;
LEVITSKY, H .
SCIENCE, 1994, 264 (5161) :961-965
[7]   Cyclosporin A alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: A clinico-pathological study [J].
Lim, SH ;
Coleman, S ;
Bull, A ;
OCallaghan, U ;
Evely, R ;
Booth, M .
BONE MARROW TRANSPLANTATION, 1997, 20 (01) :83-85
[8]  
Lim SH, 1997, AM J HEMATOL, V54, P61, DOI 10.1002/(SICI)1096-8652(199701)54:1<61::AID-AJH9>3.0.CO
[9]  
2-2
[10]   Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells [J].
Smit, WM ;
Rijnbeek, M ;
vanBergen, CAM ;
dePaus, RA ;
Vervenne, HAW ;
vandeKeur, M ;
Willemze, R ;
Falkenburg, JHF .
HUMAN IMMUNOLOGY, 1997, 53 (02) :216-223